Kezdőlap・Részvénylista・Agilent Technologies Inc

Agilent Technologies Inc

Lezárt

SzektorEgészségügy

149.31 0.71

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

147.13

Maximum

149.4

Fő mutatók
By Trading Economics
Bevétel	34M 339M
Értékesítés	37M 1.8B
P/E Szektor átlag	147.248 57.002
Egy részvényre jutó nyereség	1.49
Osztalékhozam	0.69
Profit margin	18.474
Munkavállalók	18,000
EBITDA	44M 500M

Ajánlások
By TipRanks
Ajánlások	Erős vétel
12 hónapos előrejelzés	+4.39% upside

Osztalékok
By Acuity
Osztalékhozam Szektor átlag	0.69% 2.22%
Következő eredményjelentés	2026. aug. 26.
Következő osztalékfizetési dátum	2026. okt. 21.
Következő korábbi osztalék dátum	2026. szept. 29.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	9.5B 42B
Előző nyitás	148.6
Előző zárás	149.31

Hangulat hírek alapján

By Acuity

61%

39%

285 / 340 Rangsor szerint Healthcare

Agilent Technologies Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 12. 19:26 UTC

Agilent Technologies Inc shares are lower today, continuing a decline since Tuesday's close. The stock reached a session low earlier in the session.

2026. aug. 11. 21:02 UTC

Agilent Technologies Inc. shares are lower in after-market trading, continuing a decline since Tuesday's close despite being above the 20-day moving average.

2026. aug. 7. 20:03 UTC

Agilent Technologies Inc shares are higher today, supported by strong demand and momentum above the 20-day moving average. No specific news was identified.

2026. aug. 6. 20:07 UTC

Agilent Technologies Inc shares are higher today amid mixed economic data, including increased labor productivity and rising unit labor costs. No specific company news was identified.

2026. aug. 5. 19:52 UTC

Correlated Moves

Agilent Technologies Inc is rising, driven by gains in the Life Sciences Tools & Services sector and a notable increase in Charles River Laboratories shares.

2026. aug. 4. 21:03 UTC

Agilent Technologies shares declined after hours, reversing an initial uptick. No specific news was identified to explain the movement.

2026. aug. 3. 19:26 UTC

Correlated Moves

Agilent Technologies Inc shares are rising, supported by a gain in the VanEck Morningstar Wide Moat ETF and positive trends in major indices.

2026. júl. 31. 20:03 UTC

Agilent Technologies Inc shares are lower today, impacted by a decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

2026. júl. 30. 19:58 UTC

Agilent Technologies Inc. is trading lower, continuing a decline since Wednesday's close. The Nasdaq 100 Index has increased, contrasting with Agilent's performance.

2026. júl. 29. 19:56 UTC

Agilent Technologies Inc shares are lower amid broader market pressures from rising crude oil prices and inflation concerns affecting equities.

2026. júl. 28. 23:41 UTC

Agilent Technologies shares declined in after-market trading, reflecting broader pressures in technology due to concerns over AI spending and competition from Chinese chipmakers.

2026. júl. 27. 22:36 UTC

Agilent Technologies Inc shares are higher in after-market trading, supported by strong performance. The stock remains above its 20-day moving average.

2026. júl. 24. 19:07 UTC

News

Agilent Technologies Inc shares are trading lower amid concerns over sales trends and underperformance compared to healthcare peers. The stock remains above its 20-day moving average.

2026. júl. 23. 20:03 UTC

Correlated Moves

News

Agilent Technologies received EU certification for its PD-L1 IHC 22C3 diagnostic, boosting shares during Thursday's session. This marks the eighth CE-marked indication in the EU.

2026. júl. 22. 21:46 UTC

Correlated Moves

Agilent Technologies Inc. is higher in after-market trading, supported by a rise in Thermo Fisher Scientific Inc. and overall life sciences sector performance.

2026. júl. 21. 20:02 UTC

News

Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 assay, boosting shares as analysts express positive sentiment on its future prospects.

2026. júl. 20. 19:22 UTC

News

Agilent Technologies Inc. shares are lower amid broader market declines and rising Treasury yields, despite a "Moderate Buy" consensus from analysts.

Társak összehasonlítása

Árváltozás

Agilent Technologies Inc Előrejelzés

Célár

By TipRanks

4.39% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 156.06 USD 4.39%

Magas 180 USD

Alacsony 135 USD

16 Wall Street elemző 12 hónapos célárain alapulva a(z)Agilent Technologies Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

16 ratings

Vétel

Tartás

Eladás

16 Wall Street elemző célárain alapulva a(z)Agilent Technologies Inc termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

285 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.